Condensed Consolidated Statements of Cash Flows - USD ($) $ in Millions	6 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Cash Flow from Operating Activities
Net earnings	$ 30.9	$ 34.4
Depreciation and amortization	45.6	44.6
Share-based compensation expense	13.3	12.2
Loss on sale of assets	1.0	0.4
Defined Benefit Plan, Benefit Obligation, Payment for Settlement	7.2
Deferred compensation payments	(4.7)	(7.1)
Deferred income taxes	(0.9)	(10.5)
Proceeds (payments) for other operating activities	(71.1)	(113.0)
Other, net	(19.4)	(0.9)
Net cash from (used by) operating activities	1.9	(39.9)
Cash Flow from Investing Activities
Capital expenditures	(18.8)	(25.0)
Acquisition of Billie, net of cash acquired	0.0	309.4
Collection of deferred purchase price on accounts receivable sold	0.8	4.7
Proceeds from sale of Infant and Pet Care business	(2.0)	(1.0)
Other, net	0.0	5.0
Net cash used by investing activities	(20.0)	(325.7)
Cash Flow from Financing Activities
Cash proceeds from debt with original maturities greater than 90 days	413.0	399.0
Cash payments on debt with original maturities greater than 90 days	(392.0)	(220.0)
(Payments) proceeds of debt with original maturities of 90 days or less	(1.4)	0.7
Repurchase of shares	(30.0)	(75.4)
Dividends to common shareholders	(16.1)	(16.7)
Net financing inflow (outflow) from the Accounts Receivable Facility	4.8	(0.2)
Employee shares withheld for taxes	(8.1)	(9.7)
Proceeds (payments) for other financing activities	0.8	0.6
Net cash (used by) from financing activities	(29.0)	78.3
Effect of exchange rate changes on cash	13.6	(3.8)
Net decrease in cash and cash equivalents	(33.5)	(291.1)
Cash and cash equivalents, beginning of period	188.7	479.2
Cash and cash equivalents, end of period	$ 155.2	$ 188.1